Latest News

Investment. Co-development. First to market.

Strategic investment by iGrow Venture Partners announced

Strategic investment announced, supporting Alvion's expansion into new markets and therapeutic areas as the group scales its non-infringing generics portfolio across Europe and beyond.

Read the announcement

Portfolio · First to Market

Ticagrelor film coated tablets — first to market in key EU territories

Alvion to offer a non-infringing Ticagrelor formulation, targeting first-to-market positioning across key EU territories.

Partnership · Licensing

Lupin enters licensing agreement with Alvion for Southeast Asia

Lupin Limited to commercialize Alvion's cardiometabolic medicines across Malaysia, Vietnam and the wider Southeast Asia region.

Media & Partnerships

Talk to Alvion

For media enquiries or to discuss a partnership, reach our Business Development team.

Contact Business Development